"Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2012" - New Market Report

Boston, MA -- (SBWIRE) -- 02/07/2013 -- Global Markets Direct's, 'Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease). Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.